Alnylam Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Agios Pharmaceuticals USD 16.64M 500K 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Amgen USD 1.91B 239M 2024-12
Arrowhead Research USD 14.46M 3.07M 2024-12
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Incyte USD 197.46M 18.76M 2024-12
Ionis Pharmaceuticals USD 42.96M 33.91M 2024-12
Moderna USD 405M 32M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
PTC Therapeutics USD 17.27M 3.98M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Sanofi 7.43B 105M 2024-06
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Takeda JPY 460.18B 46.85B 2024-12
Tectonic Therapeutic USD 2.64M 1.45M 2024-09
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Xencor USD 16.76M 2.01M 2024-12



Alnylam Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.